Omniscient Neurotechnology: Funding, Investors & Team (Sep 2026)
Omniscient Neurotechnology (o8t™) is a pioneering brain mapping company that is revolutionizing brain care with data. Using innovations in medical imaging and machine learning, Omniscient builds applications capable of mapping and analyzing “brain networks” which are formed by the electrical connections within a person’s brain. Such insights are illuminating the neural processes that make us human and helping clinicians and researchers understand, diagnose, and treat complex neurological and mental illnesses. Omniscient is a leader in the field of “connectomics” – the study of the brain’s connections. It recently launched Quicktome™, the world’s first medical device to harness this vital data for neurological care, providing neurosurgeons brain network information prior to life-changing surgery. The company is headquartered in Sydney, Australia with offices globally. For more information, please visit www.o8t.com.
Omniscient Neurotechnology has raised $29.9M across 1 funding round on record, the most recent a Series B of $29.9M announced in Jul 2021.
That round is above the $5.8M median round size for Artificial Intelligence companies tracked on FundedIQ over the last two years.
Omniscient Neurotechnology Company Profile and Key Stats
Latest funding round on record: Jul 2021.
Omniscient Neurotechnology Funding Rounds
Omniscient Neurotechnology Founders and Leadership Team
Contact details for the Omniscient Neurotechnology team: 1 of 1 has an email address on file.
Start 14-day free trial →Omniscient Neurotechnology Funding Compared to Other Artificial Intelligence Startups
Omniscient Neurotechnology's latest round of $29.9M is above the median round in Artificial Intelligence. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Omniscient Neurotechnology in Artificial Intelligence and Sydney
Companies Similar to Omniscient Neurotechnology
Axtec, a software platform that supports automation across the property lifecycle. The platform offers tools…
Sharon AI offers infrastructure for traditional AI and GenAI inference and training workloads, alongside…
TakeCare OS is an AI system for disability, aged care, and home care that consolidate the entire…
Vitasora Health is a healthcare technology company specializing in connected care management. It offers…
tday is a developer of AI marketing platform simplifying digital transactions between businesses and…
As organizations move from AI experiments to production systems, they face a new challenge: understanding…
Baymatob is an AI-guided solution to improve health outcomes for mothers and their babies. The company was…
XMO is building a consumer finance product centered on agentic AI and predictive money management. The…
ProcurePro develops procurement management software for construction projects. The platform supports…
InteliCare has commercialised a predictive analytics engine hardware and software system for use in the aged…
We help organisations manage digital risk, enabling them to find and resolve brand and legal compliance…
Omniscient Neurotechnology Funding FAQs
What does Omniscient Neurotechnology do?
Omniscient Neurotechnology (o8t™) is a pioneering brain mapping company that is revolutionizing brain care with data. Using innovations in medical imaging and machine learning, Omniscient builds applications capable of mapping and analyzing “brain networks” which are formed by the electrical connections within a person’s brain. Such insights are illuminating the neural processes that make us human and helping clinicians and researchers understand, diagnose, and treat complex neurological and mental illnesses. Omniscient is a leader in the field of “connectomics” – the study of the brain’s connections. It recently launched Quicktome™, the world’s first medical device to harness this vital data for neurological care, providing neurosurgeons brain network information prior to life-changing surgery. The company is headquartered in Sydney, Australia with offices globally. For more information, please visit www.o8t.com.
How much funding has Omniscient Neurotechnology raised?
Omniscient Neurotechnology has raised $29.9M across 1 round on record. The most recent is a Series B of $29.9M announced in Jul 2021.
When did Omniscient Neurotechnology last raise funding?
Omniscient Neurotechnology's most recent funding round on record is a Series B of $29.9M, announced in Jul 2021.
Who is the CEO of Omniscient Neurotechnology?
Stephen Scheeler is listed as CEO at Omniscient Neurotechnology.
Where is Omniscient Neurotechnology headquartered?
Omniscient Neurotechnology is based in Sydney, New South Wales, Australia.
How many employees does Omniscient Neurotechnology have?
Omniscient Neurotechnology is in the 51-100 employee band.
How does Omniscient Neurotechnology's funding compare to other Artificial Intelligence startups?
Omniscient Neurotechnology's latest round of $29.9M is above the $5.8M median round size for Artificial Intelligence companies on FundedIQ across 7,234 tracked companies over the last two years.
About FundedIQ's Omniscient Neurotechnology Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Omniscient Neurotechnology is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.